WallStreetZenWallStreetZen

NASDAQ: TARA
Protara Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TARA

Based on 1 analyst offering 12 month price targets for Protara Therapeutics Inc.
Min Forecast
$23.00+473.57%
Avg Forecast
$23.00+473.57%
Max Forecast
$23.00+473.57%

Should I buy or sell TARA stock?

Based on 1 analyst offering ratings for Protara Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TARA stock forecasts and price targets.

TARA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-14

1 of 1

Forecast return on equity

Is TARA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is TARA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TARA revenue forecast

What is TARA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$34.6M
Avg 2 year Forecast
$86.0M
Avg 3 year Forecast
$185.8M

TARA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TARA$4.01$23.00+473.57%Buy
BCTX$2.86$18.00+529.37%Buy
QNCX$1.06N/AN/A
ESLA$1.24N/AN/A
CADL$1.58$11.00+596.20%Buy

Protara Therapeutics Stock Forecast FAQ

Is Protara Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TARA) stock is to Buy TARA stock.

Out of 1 analyst, 0 (0%) are recommending TARA as a Strong Buy, 1 (100%) are recommending TARA as a Buy, 0 (0%) are recommending TARA as a Hold, 0 (0%) are recommending TARA as a Sell, and 0 (0%) are recommending TARA as a Strong Sell.

If you're new to stock investing, here's how to buy Protara Therapeutics stock.

What is TARA's revenue growth forecast for 2025-2027?

(NASDAQ: TARA) Protara Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Protara Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TARA's revenue for 2025 to be $395,610,760, with the lowest TARA revenue forecast at $395,610,760, and the highest TARA revenue forecast at $395,610,760. On average, 2 Wall Street analysts forecast TARA's revenue for 2026 to be $983,538,659, with the lowest TARA revenue forecast at $178,825,211, and the highest TARA revenue forecast at $1,788,252,107.

In 2027, TARA is forecast to generate $2,124,521,253 in revenue, with the lowest revenue forecast at $443,861,552 and the highest revenue forecast at $3,805,180,954.

What is TARA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TARA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TARA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TARA price target, the average TARA price target is $23.00, with the highest TARA stock price forecast at $23.00 and the lowest TARA stock price forecast at $23.00.

The Wall Street analyst predicted that Protara Therapeutics's share price could reach $23.00 by Mar 14, 2025. The average Protara Therapeutics stock price prediction forecasts a potential upside of 473.57% from the current TARA share price of $4.01.

What is TARA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TARA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.